| |
| |
BioPortfolio News : Novacea appoints Amar Singh as chief commercialization officer (Site not responding. Last check: ) |
 | | Singh joins Novacea from Abraxis Oncology, a proprietary division of American Pharmaceutical Partners, Inc., where he served as vice president of marketing and sales and successfully launched the anticancer agent, Abraxane. |
 | | At Abraxis, Singh was responsible for all commercial operations where he built the sales, marketing, business solutions and medical executive teams and directed the successful launch of Abraxane. |
 | | Singh holds a MBA degree from New York University, and a BA in economics from the University of North Carolina Chapel Hill. |
| www.bioportfolio.com /april_06/19_04_2006/Novacea_appoints_Amar_Singh.html (211 words) |
|